Want to use our logo?

Download the ICS Branding Pack

ICS Background

Dr Toby Chai
Yale University School of Medicine

View Member Details

Toby Chai

Member

Profession:Urologist
Qualifications:Professor
Privacy:
You must be logged in to view this contact
Sign-in to ICS

Dr. Chai has received national attention for his work in the treatment of urinary incontinence and his research in the field of bladder urothelial physiology. He joined the Department of Urology at Yale School of Medicine in 2013 as a professor and vice-chair of Research and holds a joint faculty position in the department of Obstetrics, Gynecology and Reproductive Sciences. After receiving his BS from Johns Hopkins University and MD from Indiana University, he completed a residency in urological surgery at the University of Michigan Medical Center. He was awarded an AUA/AFUD Research scholarship for two years of bladder physiology research under mentorships of Dr. William D. Steers and Jeremy B. Tuttle at University of Virginia in Charlottesville. Before coming to Yale, he held the John D. Young Professorship in Urology at the University of Maryland School of Medicine. Dr. Chai's research has been recognized in dozens of awards for scientific investigation and scholarship. He was awarded the 2015 Wendy U. and Thomas C. Naratil Pioneer Award for Women's Health Research at Yale, the 2015 Society for Urodynamics Female Pelvic Medicine, and Urogenital Reconstruction (SUFU) Distinguished Service Award, the 2013 American Urological Association’s Victor Politano Award for innovative research in urinary incontinence, and the 2005 SUFU Zimskind Award. His research has focused on translational urothelial biologic research in understanding how urothelial mechanisms contribute to lower urinary tract symptoms.
Dr. Chai has published more than 150 peer-reviewed articles, reviews and medical text chapters. He is the Co-Editor-in-Chief of Bladder, and Associate Editor of Journal of Urology. He serves on the Executive Committee of Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) and is the Chair of the American Urological Association (AUA) Research Advocacy Committee. He was a member of the Food and Drug Administration (FDA) Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC). He regularly reviews grant applications for the National Institutes of Health (NIH).

NO DISCLOSURE STATEMENT RECORDED
VOLUNTARY